Close this search box.

Iambic hires Josephson as CMO

ARTICLE | Management Tracks

Plus: Cole joins Cadrenal and updates from PrecisioBiotix and 60 Degrees

By Richard Guy, Biopharma Analyst

February 10, 2024 1:01 AM UTC

AI drug discovery company Iambic Therapeutics Inc. hired Neil Josephson as CMO. Josephson was CMO of Zymeworks Inc. (NASDAQ:ZYME) and succeeds interim CMO Jackie Walling, who will join the company’s clinical advisory board.

Anticoagulation company Cadrenal Therapeutics Inc. (NASDAQ:CVKD) hired Jeff Cole as COO, a newly created position. Cole was co-founder, president and CFO of Espero Biopharma Inc., and is a principal at J. Scott Capital LLC, a consulting firm. …